UCN-01 (7-Hydroxystaurosporine) is an investigational anticancer agent that is currently being evaluated as targeted therapy in phase II clinical studies. The aims of this work were to describe the population pharmaco...
Project supported by the grants of NIH and NFCR (USA); thegrant of NationalDistinguished Young Scholars(No 30025043);the National Special Research Program (No 2002AA2Z346D);and the State Key Basic R&D Programme "973" (No2002CB513108).2
AIM: To investigate whether 7-hydroxystaurosporine (UCN-01) affects cell cycle progression in arabinosylcytosine (ara-C) treatedhuman coloncarcinoma HT-29cells. METHODS:Cytotoxicity, DNA synthesis, cell cycle distrib...